Knight Therapeutics Inc. is a specialty pharmaceutical company focused on acquiring, in-licensing, out-licensing, marketing and distributing innovative prescription pharmaceuticals, consumer health products and medical devices in Canada and Latin America. Knight is publicly traded on the TSX (GUD).
3400 de Maisonneuve W.
Suite 1055
Montreal, QC Canada H3Z 3B8
Samira Sakhia
President and CEO
info@knighttx.com
Corporate Head Office
Knight Therapeutics Inc.
3400 de Maisonneuve W.
Suite 1055
Montreal, QC Canada H3Z 3B8
Email: info@knighttx.com
Transfer Agent
Registered shareholders with questions about lost certificates, transfers, change of address and other similar inquiries should contact Computershare:
Computershare
1500 Robert-Bourassa Boulevard, 7th Floor
Montreal, QC H3A 3S8
Telephone: 1-800-564-6253
Auditor
Ernst & Young LLP
More Information
To access our public filings, visit our SEDAR Profile
For other information, please contact us at info@gudknight.com or 514-484-4483
Welcome to the communications center and thank you for your interest!
To add or remove yourself from our email list, enter your email address below.
It is our goal to provide you with the highest quality of information. By completing the following form, you can request to receive corporate communications to multiple email addresses, request investor mailings, attend online corporate events and provide your valuable feedback directly to management at any time.
Thank you and we look forward to serving your information needs.
Sincerely,
Knight Therapeutics Inc.